- Investing Ideas
- /
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Selvita
Market Cap: zł587.4m
Operates as a contract research organization worldwide.
SLV
zł32.00
7D
-5.3%
1Y
-47.4%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł228.9m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł41.40
7D
2.2%
1Y
-48.3%
Molecure
Market Cap: zł159.6m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.
MOC
zł7.90
7D
0.8%
1Y
-48.6%
Poltreg
Market Cap: zł145.0m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł31.10
7D
5.8%
1Y
-40.0%